occupational asthma
Contents
Two distinct entities: sensitiser-induced (true occupational asthma — new disease caused by work) vs work-exacerbated (pre-existing asthma worsened by workplace irritants). The distinction has major implications for prognosis, management, and medicolegal outcome. Early removal from exposure is the most important intervention for sensitiser-induced disease.
classification
| Sensitiser-induced OA | Irritant-induced OA (RADS) | Work-exacerbated asthma | |
|---|---|---|---|
| Mechanism | Immunological sensitisation (latency period) | High-level irritant exposure → airway injury | Pre-existing asthma worsened by workplace triggers |
| Latency | Weeks to years of exposure before symptom onset | Onset within 24h of single high-dose exposure | N/A |
| Pre-existing asthma | No (new disease) | No | Yes |
| Prognosis with removal | May improve or resolve | Often persistent | Improves but underlying asthma remains |
| Medicolegal | Compensable workplace disease | Compensable | Generally not compensable as occupational disease |
common sensitisers
| Agent | Occupation |
|---|---|
| Isocyanates (TDI, MDI, HDI) | Spray painters, insulation workers, auto body |
| Flour / grain dust | Bakers, millers |
| Wood dust (western red cedar) | Carpenters, sawmill workers |
| Latex | Healthcare workers |
| Laboratory animals | Research technicians |
| Enzymes (subtilisins) | Detergent manufacturing |
| Metals (platinum salts, chromium) | Welders, platers |
| Persulfates | Hairdressers |
The most common cause of occupational asthma in industrialised countries. Exposure can occur even at very low concentrations. Ask about spray painting, foam manufacturing, and insulation work.
when to suspect
- Asthma onset as an adult with no prior history (especially if atopic) — 5–20% of new adult-onset asthma is attributable to occupational exposure
- Occupational rhinitis preceding asthma symptoms (may precede OA by up to a year — an early warning sign)
- Symptoms improve on weekends, holidays, or time away from work
- Symptoms worsen during or shortly after work shifts
- Multiple co-workers with similar symptoms
- Exposure to known high-risk agents
diagnosis
Step 1: Confirm asthma — objective evidence of variable airflow limitation (spirometry, methacholine challenge)
Step 2: Establish work-relatedness
| Test | Method | Notes |
|---|---|---|
| Serial PEF monitoring | ≥ 4 readings/day for ≥ 2 weeks at work and 2 weeks away | Gold standard for demonstrating work-related variability; interpret with OASYS score; requires patient compliance |
| Methacholine challenge | At work vs after ≥ 2 weeks away | PC20 decreases (worsens) at work; ≥ 3.2-fold improvement in PC20 off work supports OA |
| Specific IgE / skin prick | For high-molecular-weight agents (proteins, latex) | Supports sensitisation; does not confirm causation |
| Specific inhalation challenge (SIC) | Controlled exposure in specialised lab | Gold standard for confirming specific agent; limited availability |
Step 3: Identify the causative agent — occupational hygiene assessment, MSDS review
management
sensitiser-induced OA
- Complete removal from exposure — the earlier the better. Continued exposure leads to progressive, irreversible decline
- Pharmacological treatment same as general asthma guidelines
- Workers’ compensation referral — document diagnosis thoroughly
- Monitor after removal: improvement may take months to years; up to 70% have persistent asthma despite removal — prognosis improves with earlier diagnosis and removal
- Retraining / job modification if same workplace
work-exacerbated asthma
- Optimise asthma treatment per asthma guidelines
- Reduce workplace irritant exposure (engineering controls, PPE)
- Complete removal from work usually not necessary
- May benefit from pre-shift bronchodilator use in some cases
what NOT to do
- Label all work-related symptoms as “occupational asthma” — work-exacerbated asthma is far more common and managed differently
- Diagnose OA without objective evidence (serial PEF, methacholine, or SIC)
- Delay removal from exposure in confirmed sensitiser-induced OA — prognosis worsens with continued exposure
- Forget to notify public health/workplace safety where mandated
- Assume normal spirometry excludes OA — spirometry may be normal between exposures; methacholine challenge or serial PEF is needed